Intraocular pressure effect of anti-vascular endothelial growth factor injection for aggressive posterior retinopathy of prematurity

被引:0
作者
Ozdemir Ozdemir
Aysegul Arman
Cuneyt Tayman
机构
[1] Ankara City Hospital,Department of Ophthalmology
[2] University of Health Sciences,Department of Ophthalmology
[3] Ankara City Hospital,Division of Neonatology
[4] Ankara City Hospital,undefined
[5] University of Health Sciences,undefined
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2021年 / 259卷
关键词
Aflibercept; Aggressive posterior; Anti-VEGF; Bevacizumab; Intraocular pressure; Intravitreal injection; Ranibizumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3469 / 3476
页数:7
相关论文
共 50 条
  • [21] Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor Era
    Carroll, Robert M.
    Bracha, Peter
    Miller, Charles G.
    Brucker, Alexander J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (03): : 461 - 463
  • [22] Effect of different lens status on intraocular pressure elevation in patients treated with anti-vascular endothelia growth factor injections
    Sternfeld, Amir
    Ehrlich, Rita
    Weinberger, Dov
    Dotan, Assaf
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (01) : 79 - 84
  • [23] Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Hoang, Quan V.
    Mendonca, Luis S.
    Della Torre, Kara E.
    Jung, Jesse J.
    Tsuang, Angela J.
    Freund, K. Bailey
    OPHTHALMOLOGY, 2012, 119 (02) : 321 - 326
  • [24] Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
    Shah, Neepa
    Gupta, Mrinali P.
    Chan, R. V. Paul
    JAMA OPHTHALMOLOGY, 2018, 136 (04) : 436 - 437
  • [25] RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY
    Ling, Kiet-Phang
    Liao, Pei-Ju
    Wang, Nan-Kai
    Chao, An-Ning
    Chen, Kuan-Jen
    Chen, Tun-Lu
    Hwang, Yih-Shiou
    Lai, Chi-Chun
    Wu, Wei-Chi
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (09): : 1793 - 1803
  • [26] REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY
    Cernichiaro-Espinosa, Linda A.
    Harper, Clio A., III
    Read, Sarah P.
    Wright, Lauren M.
    Scribbick, Frank W., III
    Young, Ryan
    Negron, Catherin I.
    Rodriguez, Ana
    Berrocal, Audina M.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06): : 1251 - 1255
  • [27] Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
    Kondo, Chiori
    Iwahashi, Chiharu
    Utamura, Shoko
    Kuniyoshi, Kazuki
    Konishi, Yuhei
    Wada, Norihisa
    Kawasaki, Ryo
    Kusaka, Shunji
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [28] Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis
    Xu, Yufei
    Deng, Guohua
    Zhang, Jun
    Zhu, Jie
    Liu, Zhinan
    Xu, Fan
    Zhou, Dong
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 676 - 687
  • [29] FLUORESCEIN ANGIOGRAPHY EVALUATION OF CHILDREN PREVIOUSLY TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY FOR RETINOPATHY OF PREMATURITY
    Poslu Karademir, Fatma
    Vural, Asli
    Ozbas, Mehmet
    Demirayak, Bengi
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (05): : 901 - 908
  • [30] Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
    Martinez-Zapata, Maria Jose
    Salvador, Ignacio
    Marti-Carvajal, Arturo J.
    Pijoan, Jose I.
    Cordero, Jose A.
    Ponomarev, Dmitry
    Kernohan, Ashleigh
    Sola, Ivan
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):